HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sergej Konoplev Selected Research

Breast Implants (Breast Implant)

1/2020Unusual Case of Anaplastic Large Cell Lymphoma Presenting as a Breast Mass in a Patient with no History of Breast Implants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sergej Konoplev Research Topics

Disease

17Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 03/2007
13Leukemia
01/2020 - 06/2009
12Neoplasms (Cancer)
01/2022 - 06/2012
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 01/2011
7Hypoxia (Hypoxemia)
01/2020 - 01/2011
5Acute Promyelocytic Leukemia
06/2018 - 12/2007
4Lymphoma (Lymphomas)
01/2021 - 03/2011
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2020 - 10/2007
2Primary Myelofibrosis (Myelosclerosis)
02/2022 - 05/2015
2Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 02/2012
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2022 - 01/2020
2Thrombocytopenia (Thrombopenia)
01/2022 - 01/2021
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2021 - 09/2007
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2020 - 11/2013
2Hodgkin Disease (Hodgkin's Disease)
12/2020 - 01/2016
2Residual Neoplasm
03/2017 - 01/2017
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2014 - 01/2008
2Paraproteinemias (Monoclonal Gammopathy)
09/2012 - 03/2011
1Fever of Unknown Origin
01/2022
1Leukocytosis (Pleocytosis)
01/2022
1Chromosome Aberrations (Chromosome Abnormalities)
01/2022
1Anemia
01/2022
1Infections
01/2022
1Hemorrhage
01/2021
1Urinary Tract Infections (Urinary Tract Infection)
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2020
1Disease Progression
01/2019
1Cutaneous Mastocytosis
01/2019
1Hairy Cell Leukemia
12/2018
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2018
1Brain Neoplasms (Brain Tumor)
01/2018
1Systemic Mastocytosis
10/2016
1Large Granular Lymphocytic Leukemia
10/2015
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2013

Drug/Important Bio-Agent (IBA)

4ProdrugsIBA
04/2016 - 01/2011
3Proteins (Proteins, Gene)FDA Link
01/2019 - 08/2012
3Imatinib Mesylate (Gleevec)FDA Link
10/2016 - 01/2008
2CreatinineIBA
01/2022 - 10/2011
2venetoclaxIBA
01/2021 - 12/2018
2IACS-010759IBA
01/2020 - 01/2018
2pimonidazoleIBA
01/2020 - 07/2015
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2019 - 06/2009
2Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2018 - 12/2007
2TH 302IBA
04/2016 - 01/2016
2Sorafenib (BAY 43-9006)FDA Link
04/2016 - 06/2009
2NucleophosminIBA
12/2013 - 10/2009
2CXCR4 Receptors (CXCR4 Receptor)IBA
12/2013 - 03/2007
2Phosphotransferases (Kinase)IBA
06/2012 - 06/2009
2TriterpenesIBA
06/2012 - 05/2007
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1AntigensIBA
01/2022
1nelarabine (506U78)FDA Link
01/2021
1eltrombopagFDA Link
01/2021
1Lymphoid Enhancer-Binding Factor 1IBA
12/2020
1Oxygen (Dioxygen)IBA
01/2020
1fludarabineIBA
01/2019
1Busulfan (Busulfex)FDA Link
01/2019
1Immunoglobulin E (IgE)IBA
01/2019
1Omalizumab (Xolair)FDA Link
01/2019
1plerixaforFDA Link
01/2019
1ibrutinibIBA
12/2018
1Arsenic Trioxide (Trisenox)FDA Link
06/2018
1Aspartic Acid (Aspartate)FDA Link
01/2018
1NucleotidesIBA
01/2018
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2017
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2017
1Cytokine Receptors (Cytokine Receptor)IBA
01/2017
1Glutamine (L-Glutamine)FDA Link
11/2016
1GlutaminaseIBA
11/2016
1IsoenzymesIBA
11/2016
1Protein Isoforms (Isoforms)IBA
11/2016
1Cytotoxins (Cytolysins)IBA
04/2016
1Pharmaceutical PreparationsIBA
04/2016
1Tyrosine Kinase InhibitorsIBA
04/2016
1Pyruvic Acid (Pyruvate)IBA
04/2016
1Core Binding Factor Alpha 2 SubunitIBA
02/2016
1Rituximab (Mabthera)FDA Link
01/2016
1Lenalidomide (CC 5013)FDA Link
01/2016
1Biological ProductsIBA
10/2015
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2015
1LY2510924IBA
07/2015
1CXC ChemokinesIBA
07/2015
1Carbonic Anhydrase IXIBA
07/2015
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2015
1Integrin alpha4beta1 (VLA-4)IBA
04/2014
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
04/2014
1Dasatinib (BMS 354825)FDA Link
02/2014
1Monoclonal AntibodiesIBA
11/2013
1Retinoic Acid Receptor alphaIBA
08/2013
1OligonucleotidesIBA
08/2013

Therapy/Procedure

14Therapeutics
01/2022 - 10/2007
9Drug Therapy (Chemotherapy)
01/2022 - 06/2009
3Hematopoietic Stem Cell Transplantation
02/2022 - 05/2007
2Aftercare (After-Treatment)
06/2018 - 05/2015
2Induction Chemotherapy
01/2018 - 01/2017
1Transplantation
01/2021
1Breast Implants (Breast Implant)
01/2020
1Stem Cell Transplantation
01/2019
1Immunotherapy
11/2013